Study the effect of syrup Rubyclin and Dadruvidravan ointment in skin disease

Clinical Study To Evaluate Efficacy Of Liquid Rubyclin And Dadruvidravan Malhar In Dadru With Special Reference To Ringworm

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027972

Enrollment

Registered

2020-09-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Liquid Rubyclin: 20 ml twice a daily for 30 Days Control Intervention1: Dadruvidravan malhar: 5 gms twice daily topically for 30 Days Control Intervention2: Liquid Rubyclin and Dadruvid

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical signs and symptoms of the Dadru kushta like kandu (Itching) Raga (Redness) Pidika (Papules) Not suffering from any other chronic infectious disease including HIV Patient willing to participate in study and those who give written consent

Exclusion criteria

Exclusion criteria: The pregnant and lactating mother Patient with uncontrolled systemic disorders like DM Hypertension Cardiac disorder psoriasis Leprosy Tuberculosis Malignancy etc

Design outcomes

Primary

Measure	Time frame
Reduction in sign symptoms of Dadru Reduction in affected areaTimepoint: 30 days	—

Secondary

Measure	Time frame
Normalization of skinTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Eknath Kulkarni

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik

ekulkarni6@gmail.com9850071240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026